# Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

> **NCT00216151** · PHASE2 · TERMINATED · sponsor: **Hoosier Cancer Research Network** · enrollment: 3 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT00216151
- **Lead sponsor:** Hoosier Cancer Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study terminated due to low patient enrollment.
- **Last updated:** 2011-05-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216151, "Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00216151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*